Provided by Tiger Fintech (Singapore) Pte. Ltd.

Evaxion Biotech A/S

1.65
+0.06003.77%
Post-market: 1.700.0500+3.03%19:58 EDT
Volume:59.80K
Turnover:97.98K
Market Cap:10.34M
PE:-0.17
High:1.70
Open:1.59
Low:1.59
Close:1.59
Loading ...
Jan 12, 2024

Public Prospectus

Form F-1 - Registration statement for certain foreign private issuers
Apr 28, 2023

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Aug 24, 2022

Correspondence

CORRESP [Cover] - Correspondence
Aug 22, 2022

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Jul 07, 2022

Public Prospectus

F-1 - Registration statement for certain foreign private issuers
Jun 01, 2022

Correspondence

CORRESP [Cover] - Correspondence
Mar 31, 2022

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Oct 29, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 29, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 26, 2021

Public Prospectus

F-1 - Registration statement for certain foreign private issuers
May 13, 2021

important event

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 07, 2021

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Apr 06, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Apr 06, 2021

important event

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 02, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 02, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 01, 2021

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Feb 01, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 25, 2021

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Jan 22, 2021

Correspondence

CORRESP [Cover] - Correspondence